Rational design of potent non-nucleoside inhibitors of HIV-1 reverse transcriptase. 2012

Pek Chong, and Paul Sebahar, and Michael Youngman, and Dulce Garrido, and Huichang Zhang, and Eugene L Stewart, and Robert T Nolte, and Liping Wang, and Robert G Ferris, and Mark Edelstein, and Kurt Weaver, and Amanda Mathis, and Andrew Peat
GlaxoSmithKline Research & Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, United States.

A new series of non-nucleoside reverse transcriptase inhibitors based on an imidazole-amide biarylether scaffold has been identified and shown to possess potent antiviral activity against HIV-1, including the NNRTI-resistant Y188L mutated virus. X-ray crystallography of inhibitors bound to reverse transcriptase, including a structure of the Y188L RT protein, was used extensively to help identify and optimize the key hydrogen-bonding motif. This led directly to the design of compound 43 that exhibits remarkable antiviral activity (EC50<1 nM) against a wide range of NNRTI-resistant viruses and a favorable pharmacokinetic profile across multiple species.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

Pek Chong, and Paul Sebahar, and Michael Youngman, and Dulce Garrido, and Huichang Zhang, and Eugene L Stewart, and Robert T Nolte, and Liping Wang, and Robert G Ferris, and Mark Edelstein, and Kurt Weaver, and Amanda Mathis, and Andrew Peat
June 2007, Bioorganic & medicinal chemistry letters,
Pek Chong, and Paul Sebahar, and Michael Youngman, and Dulce Garrido, and Huichang Zhang, and Eugene L Stewart, and Robert T Nolte, and Liping Wang, and Robert G Ferris, and Mark Edelstein, and Kurt Weaver, and Amanda Mathis, and Andrew Peat
February 2019, ACS medicinal chemistry letters,
Pek Chong, and Paul Sebahar, and Michael Youngman, and Dulce Garrido, and Huichang Zhang, and Eugene L Stewart, and Robert T Nolte, and Liping Wang, and Robert G Ferris, and Mark Edelstein, and Kurt Weaver, and Amanda Mathis, and Andrew Peat
March 2020, Bioorganic chemistry,
Pek Chong, and Paul Sebahar, and Michael Youngman, and Dulce Garrido, and Huichang Zhang, and Eugene L Stewart, and Robert T Nolte, and Liping Wang, and Robert G Ferris, and Mark Edelstein, and Kurt Weaver, and Amanda Mathis, and Andrew Peat
February 2006, Bioorganic & medicinal chemistry letters,
Pek Chong, and Paul Sebahar, and Michael Youngman, and Dulce Garrido, and Huichang Zhang, and Eugene L Stewart, and Robert T Nolte, and Liping Wang, and Robert G Ferris, and Mark Edelstein, and Kurt Weaver, and Amanda Mathis, and Andrew Peat
June 2014, Bioorganic & medicinal chemistry,
Pek Chong, and Paul Sebahar, and Michael Youngman, and Dulce Garrido, and Huichang Zhang, and Eugene L Stewart, and Robert T Nolte, and Liping Wang, and Robert G Ferris, and Mark Edelstein, and Kurt Weaver, and Amanda Mathis, and Andrew Peat
December 2010, Journal of medicinal chemistry,
Pek Chong, and Paul Sebahar, and Michael Youngman, and Dulce Garrido, and Huichang Zhang, and Eugene L Stewart, and Robert T Nolte, and Liping Wang, and Robert G Ferris, and Mark Edelstein, and Kurt Weaver, and Amanda Mathis, and Andrew Peat
February 2006, Current opinion in investigational drugs (London, England : 2000),
Pek Chong, and Paul Sebahar, and Michael Youngman, and Dulce Garrido, and Huichang Zhang, and Eugene L Stewart, and Robert T Nolte, and Liping Wang, and Robert G Ferris, and Mark Edelstein, and Kurt Weaver, and Amanda Mathis, and Andrew Peat
December 2013, Future medicinal chemistry,
Pek Chong, and Paul Sebahar, and Michael Youngman, and Dulce Garrido, and Huichang Zhang, and Eugene L Stewart, and Robert T Nolte, and Liping Wang, and Robert G Ferris, and Mark Edelstein, and Kurt Weaver, and Amanda Mathis, and Andrew Peat
September 2006, Bioorganic & medicinal chemistry letters,
Pek Chong, and Paul Sebahar, and Michael Youngman, and Dulce Garrido, and Huichang Zhang, and Eugene L Stewart, and Robert T Nolte, and Liping Wang, and Robert G Ferris, and Mark Edelstein, and Kurt Weaver, and Amanda Mathis, and Andrew Peat
September 2015, European journal of medicinal chemistry,
Copied contents to your clipboard!